Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study
~26 mi.
(Baton Rouge,
Louisiana,
+523 more cities)
Study of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11/GOG-3047)
~26 mi.
(Baton Rouge,
Louisiana,
+147 more cities)
Our Lady of the Lake Regional Medical Center. ( Site 0031)
A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease.
~26 mi.
(Baton Rouge,
Louisiana,
+230 more cities)
A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05)
~26 mi.
(Baton Rouge,
Louisiana,
+356 more cities)
Our Lady of the Lake Physician Group,
+2 more
facilities
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
~26 mi.
(Baton Rouge,
Louisiana,
+825 more cities)
Our Lady of the Lake Physicians Group - Medical Oncology,
+8 more
facilities
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer
~26 mi.
(Baton Rouge,
Louisiana,
+102 more cities)